Brain Cancer Clinical Trials in San Antonio

Showing 41-60 of 142 trials

VB-111 in Surgically Accessible Recurrent/Progressive GBM

NCT04406272

This research study is studying a new viral cancer therapy, ofranergene obadenovec (VB-111), for recurrent or progressive glioblastoma (GBM), a brain tumor that is growing or progressing despite earlier treatment.

GlioblastomaRecurrent Glioblastoma

Dana-Farber Cancer Institute15 participantsStarted Aug 2020

Los Angeles, California, United States • Boston, Massachusetts, United States • San Antonio, Texas, United States +1 more locations

RECRUITINGPhase 1< 1 mile

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

NCT05460507

This is an open-label, multicenter, Phase 1 study to establish the safety and efficacy/tolerability of a single dose of 186RNL by the intraventricular route (via intraventricular catheter) for recurrence glioma in patients who received a prior treatment of 186RNL.

Glioma

Plus Therapeutics40 participantsStarted Dec 2024

San Antonio, Texas, United States

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Brain Cancer Trials in Other Cities

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

A Study of Abemaciclib in Recurrent Glioblastoma

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

9-ING-41 in Pediatric Patients With Refractory Malignancies.

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Oral ONC201 in Adult Recurrent Glioblastoma

Other Conditions in San Antonio